Enhancement of carcinoembryonic antigen (CEA) expression in colorectal tumors by neuraminidase.
Twelve colorectal carcinomas with transitional mucosa and 10 colorectal adenomas which previously displayed weak or no carcinoembryonic antigen (CEA) expression were selected to verify whether neuraminidase unmasks CEA carbohydrate epitopes and, consequently, enhances the CEA expression. Peroxidase-antiperoxidase (PAP) method was performed on routinely processed tissues, without and with neuraminidase pretreatment of the sections. Lysine, without and with neuraminidase pretreatment of the sections. Lysine, as a modifier of electrostatic charge at cell surface, instead of neuraminidase was used to clarify whether the enzyme yields a specific or non-specific influence on CEA expression. All colorectal tumors exhibited more CEA after neuraminidase pretreatment, while previous negative specimens developed CEA expression. The same effect was observed in some transitional mucosa sections. This has not occurred in normal mucosa, probably owing to a resistant sialylation. The enhancement effect of lysine, although more weakly and not entirely superimposed to that or neuraminidase, suggests non-specific mechanisms of enzyme action. The removal of the negative charge at cell surface, especially due to sialic acid, allows more anti-CEA antibodies to react. The neuraminidase pretreatment of the sections is a useful method to demonstrate the real incidence of CEA in the colorectal tumors.
Dejica
D I
DI
IIIrd Medical Clinic, University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Vierbuchen
M
M
Fischer
R
R
D000236:Adenoma / Q000276:immunology*; D002272:Carcinoembryonic Antigen / Q000032:analysis* / Q000187:drug effects; D002277:Carcinoma / Q000276:immunology*; D015179:Colorectal Neoplasms / Q000276:immunology*; D000939:Epitopes / Q000032:analysis / Q000187:drug effects; D006801:Humans; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000187:drug effects / Q000276:immunology; D008239:Lysine / Q000494:pharmacology; D009439:Neuraminidase / Q000494:pharmacology*
D002272:Carcinoembryonic Antigen; D000939:Epitopes; D009439:Neuraminidase; D008239:Lysine